ACET
NASDAQ
$7.89
Adicet Bio Inc (ACET)
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company is headquartered in Boston, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $34.83 (+341.44%)
Market Cap
$83M
PEG Ratio
0.82
P/B Ratio
0.57
Beta (5Y)
1.16
Price Chart
Valuation
Market Cap$83M
PEG0.82
P/S9.72
P/B0.57
Profitability
Gross Profit (TTM)$25M
EBITDA-$108M
EPS-$16.45
Growth & Risk
EPS 5Y CAGR+1.79%
FCF 5Y CAGR+16.17%
Beta (5Y)1.16
Sharpe Ratio-0.31